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synthesis. Either way, the results suggest
that peptidoglycan synthesis is subject to
external controls that have heretofore
escaped detection, and it is thus worth
investigating how such regulation may
be accomplished in other organisms.
Why are these results surprising? First,
LpoA and LpoB are the first regulators of
the high molecular weight penicillin-
binding proteins. It is likely that such regu-
lation exists to meet some physiological
need, which awaits discovery. Second, it
is not only their existence but their loca-
tion that is surprising. The fact that the
lipoproteins are tethered to the outer
membrane means they must cross the
peptidoglycan layer to make contact
with the penicillin-binding proteins, which
are tethered to the inner membrane
(Figure 1). Paradis-Bleau et al. speculate
that the lipoproteins may guide peptido-1044 Cell 143, December 23, 2010 ª2010 Elsglycan synthesis along defined tracks.
Typas et al. suggest that the lipoproteins
may control the rate or location of new
synthesis by reaching through holes in
the peptidoglycan to contact and activate
the PBPs, which are tethered to the inner
membrane on the other side of the wall.
There are, no doubt, other possibilities.
Finally, the reports raise many ques-
tions. Do Gram-positive bacteria, which
don’t have an outer membrane but have
a much thicker peptidoglycan layer, also
express proteins that regulate penicillin-
binding proteins? And if so, where in the
cell are these proteins located? Can cell
wall synthesis be reconstituted in vitro?
Are there any other important cell wall
agents that we don’t know about, and
might any of these new components
serve as targets for antibiotics? Future
studies to address these and other ques-evier Inc.tions should reveal whole new vistas of
the bacterial cell wall.REFERENCES
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Two key events inWnt signal transduction, receptor endocytosis and inactivation of Glycogen Syn-
thase Kinase 3 (GSK3), remain incompletely understood. Taelman et al. (2010) discover that Wnt
signaling inactivates GSK3 by sequestering the enzyme in multivesicular bodies, thus linking these
two events and providing a new framework for understanding Wnt signaling.Cell-cell signaling via thecanonicalWnt/b-
catenin pathway underlies numerous
processes in development, and its mis-
regulation is associated with human
disease, notably cancer. At the heart of
canonical Wnt signaling is derepression
of the cytoplasmic protein b-catenin. In
the absence of Wnt signaling, b-catenin
is rapidly targeted for degradation due to
phosphorylation by Glycogen Synthase
Kinase 3 (GSK3). In the presence of Wntsignaling, the phosphorylation of b-cate-
nin by GSK3 is suppressed, and b-catenin
becomes dephosphorylated and stabi-
lized and enters the nucleus to regulate
Wnt target gene transcription. Exactly
how Wnt signaling suppresses GSK3
activity remains one of the unsolved
mysteries in Wnt signaling. Another un-
solved question inWnt signaling concerns
the requirement for receptor endocytosis.
The work of Taelman et al. (2010) nowelegantly provides an answer to both of
these open questions with the discovery
that Wnt signaling triggers GSK3 seques-
tration in multivesicular bodies, a late
endocytic compartment that harbors in-
tralumenal vesicles.
Wnt/b-catenin signaling is mediated by
high-affinity Wnt receptors of the seven-
pass transmembrane Frizzled family and
a coreceptor, the low-density lipoprotein
(LDL)-receptor related protein 6 (LRP6).
Figure 1. Multivesicular Bodies in Wnt/b-Catenin Signaling
Wnt ligands bind receptors, the LDL-receptor related protein 6 (LRP6), and Frizzled. Receptor complexes
cluster on platforms of oligomerized Dishevelled (Dvl). Internalization of theWnt-receptor complex begins,
engaging the Pro-renin receptor (PRR) adaptor protein and vacuolar ATPase (v-ATPase). v-ATPase
promotes vesicle acidification, which is essential for endocytosis and vesicle traffic. Receptor clustering
triggers LRP6 phosphorylation by Casein kinase 1 gamma (CK1g), as well as recruitment of GSK3 and the
destruction complex, which includes Axin. Signalosomes are recruited to the ESCRT (endosomal sorting
complex required for transport) complex and sorted to vesicles destined for intralumenal budding. MVB
formation sequesters GSK3, Dishevelled, Axin, and b-catenin from the cytoplasm. As a result, hundreds
of cytoplasmic proteins are protected from GSK3-targeted degradation. Among them is b-catenin, which
accumulates and enters the nucleus.Upon ligand binding, Wnt, Frizzled, and
LRP6 form a ternary signaling complex
that clusters on polymers of the scaffold
protein Disheveled to form endocytic sig-
nalosomes (Bilic et al., 2007) (Figure 1).
Formation of signalosomes promotes
phosphorylationofLRP6,which is required
for signal transmission. LRP6 phosphory-
lation occurs at so-called PPSP motifs
and can be either dependent or indepen-
dent of Wnt signaling, involving a variety
of kinases including GSK3. GSK3 phos-
phorylates the PPSP motif of LRP6 upon
Wnt binding (Zeng et al., 2005) and thus
hasnotonlyanegative role inWntsignaling
(via b-catenin phosphorylation) but also
a positive one. LRP6 phosphorylation pro-
motes recruitment of the b-catenin des-truction complex consisting of GSK3,
Axin, and Adenomatous Polyposis Coli
(APC), which negatively regulate b-catenin
by promoting its proteolysis. Their recruit-
ment to the receptor complex inactivates
GSK3andderepressesb-catenin, allowing
it to accumulate, enter the nucleus, and
engage in transcriptional activation.
How Wnt signaling inactivates GSK3 is
unclear. In lysates derived from cells that
have been stimulatedwithWnt, the reduc-
tion in GSK3 enzyme activity is only tran-
sient, lasting about 1 hr (Ding et al., 2000;
Taelman et al., 2010). This transient
suppression may be due to direct inhibi-
tion of GSK3 by phosphorylated LRP6
(Piao et al., 2008) but does not explain
the sustained GSK3 inhibition. Now Tael-Cell 143, Deman et al. show thatWnt signaling triggers
sequestration of GSK3 in multivesicular
bodies, ‘‘imprisoning’’ the kinase and
protecting potential substrates. Seques-
tration of GSK3 may account for the sus-
tained inhibition of the enzyme.
GSK3 was known to accumulate in en-
docytic LRP6 signalosomes, but the
nature of these endocytic vesicles has
been unclear. Taelman et al. reveal that
signalosomes colocalize with the late en-
dosomal markers Rab7 and Vps4. Late
endosomes can give rise to multivesicluar
bodies (MVBs) when a portion of the en-
dosome membrane buds into its own
lumen. Importantly, the topology is such
that the cytoplasmic side of the plasma
membrane, where GSK3 is bound, corre-
sponds to the lumen of theMVBs, thereby
separating GSK3 from the cytosol with
two lipid bilayers (Figure 1). By electron
microscopy and biochemical analysis
the authors demonstrate that upon Wnt
stimulation GSK3 is indeed sequestered
in MVBs. Furthermore, the authors show
that Wnt signaling requires the ESCRT
(endosomal sorting complexes required
for transport) complex, which is essential
for MVB biogenesis, providing further
support for the role of MVBs in Wnt
signaling. The sequestration of GSK3 in
MVBs is thus one reason canonical Wnt
signaling requires endocytosis of Wnt
receptor complexes (Kikuchi and Yama-
moto, 2007), but it may not be the only
one. For example, endocytosis is also
required for noncanonical Wnt signaling
(Yu et al., 2007), where GSK3 does not
play a negative role. Likewise, recent
work shows that vesicle acidification,
which is mediated by vacuolar ATPase
and occurs during endosomal traffic, is
required for canonical and noncanonical
Wnt signaling (Cruciat et al., 2010). Thus,
endocytosis may play other roles in Wnt
signaling beyond MVB formation.
What is the final fate of signalosome
MVBs? Although MVBs typically fuse
with lysosomes to degrade their content,
Wnt signaling does not induce a signifi-
cant reduction in GSK3 levels, suggesting
that the signalosomes are stable. Indeed,
in certain cells MVBs can give rise to
specialized, secretory granules such as
Weibel-Palade bodies of endothelial cells,
alpha granules of platelets, or mast cell
granules. Notably, MVBs can give rise to
exosomes, secreted vesicles that arecember 23, 2010 ª2010 Elsevier Inc. 1045
produced by a wide range of mammalian
cells and can shuttle from one cell to
another. These vesicles are reminiscent
of ‘‘argosomes’’ in Drosophila imaginal
discs, vesicles that travel through adja-
cent tissue and colocalize with the Wing-
less protein, the Drosophila Wnt homolog
(Greco et al., 2001). It is therefore an
intriguing possibility that signalosome
MVBs containing the entire Wnt transduc-
tionmachinery can be secreted and affect
Wnt signaling in neighboring cells.
Remarkably, the authors also demon-
strate, using protein labeling and pulse-
chase experiments, that the inhibition of
GSK3 by Wnt signaling not only regulates
b-catenin activity but also affects the half-
life of 20% of all cellular proteins. This
finding is consistent with a recent bioinfor-
matic analysis, predicting that hundreds of
GSK3 substrates may be degraded via the
b-TrCP (b-transducing repeat-containing
protein) ubiquitin ligase pathway (Xu et al.,
2009). Thus, beyond b-catenin regulation,
a major role of GSK3 and Wnt signaling is
control of global protein half-life.
The study raises many new questions.
For example, whereas signalosome for-
mation and b-catenin stabilization occur
within minutes of Wnt treatment, Taelman
et al. only monitored GSK3 sequestration
in MVBs after a few hours of Wnt treat-
ment. The different timescales raise the
possibility that the fast inhibition of1046 Cell 143, December 23, 2010 ª2010 ElsGSK3 during Wnt signaling may occur
via binding to phospho-LRP6, whereas
sustained inhibition occurs by sequestra-
tion. On the other hand, classical work on
the kinetics of MVB formation has shown
that more than 70% of an epidermal
growth factor:ferritin complex reaches
MVBs within 15 min after internalization.
This rate fits rather well with the fast
kinetics of GSK3 inactivation (Ding et al.,
2000) as well as live-cell imaging kinetics
of signalosome formation (Bilic et al.,
2007). Thus the impact of transient versus
sustained GSK3 inhibition and the relative
contribution of phosho-LRP6 and MVB
toward GSK3 inhibition remain to be
resolved. Another conundrum is the un-
expected finding that b-catenin itself
localizes in MVBs and is required for
MVB formation, a function that is clearly
separate from its transcriptional role. If
cytoplasmic b-catenin localizes in signal-
osome MVBs, how does it escape and
travel to the nucleus? The authors
suggest that it may be newly synthesized
b-catenin that travels to the nucleus.
Alternatively, b-catenin released from
plasma membrane stores may translo-
cate to the nucleus. Finally, the emerging
role of GSK3 as a global regulator of
protein half-life may herald a paradigm
change from the predominantly transcrip-
tion-centric view of Wnt signaling. Exami-
nation of the many putative GSK3evier Inc.substrates will provide a new perspective
of downstream effects elicited by Wnt
signaling and the function of GSK3 in
multiple cellular processes and signaling
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